Società

Non verificato

Biotalys NV

Di cosa scriviamo

Annunci EconomiciFinanzaLegge/Diritto/FiscoManagement/Organizzazione AziendalePubblicità/Marketing/Media/Comunicazione

43 comunicati stampa

Guarda tutti i comunicati

08/11/2026

Pubblicità/Marketing/Media/Comunicazione

Biotalys Achieves Critical Manufacturing Milestone for First Commercial Biofungicide EVOCA® NG

Fonte

Biotalys NV

Emittente

GLOBENEWSWIRE

1.00

02/11/2026

Pubblicità/Marketing/Media/Comunicazione

Biotalys’ First Commercial Biofungicide EVOCA® NG Approved for Large-Scale Commercial Field Trials in the Netherlands

Fonte

Biotalys NV

Emittente

GLOBENEWSWIRE

1.00

13/10/2026

Finanza

Press Release - Regulated Information

Fonte

Biotalys NV

Emittente

GLOBENEWSWIRE

1.00

27/09/2026

Industry Leaders Christine Berwaerts and Ioana Tudor Join Biotalys’ Board as Independent Directors

Fonte

Biotalys NV

Emittente

GLOBENEWSWIRE

1.00

01/09/2026

Biotalys Secures Product Registration in California for EVOCA®, Strengthening Regulatory Pathway for Its Lead Asset EVOCA NG

Fonte

Biotalys NV

Emittente

GLOBENEWSWIRE

1.00

19/08/2026

Management/Organizzazione Aziendale

Biotalys Reports Half-Year 2026 Financial Results & Business Highlights

Fonte

Biotalys NV

Emittente

GLOBENEWSWIRE

1.00

06/07/2026

Management/Organizzazione Aziendale

Biotalys Notice of Publication Half Year 2026 Financial Results and Business Highlights

Fonte

Biotalys NV

Emittente

GLOBENEWSWIRE

1.00

30/06/2026

Annunci Economici

Biotalys Advances towards Registration of EVOCA in California with Start of Public Consultation

Fonte

Biotalys NV

Emittente

GLOBENEWSWIRE

1.00

30/06/2026

Biotalys Announces Retirement of Board Member Patrick Van Beneden

Fonte

Biotalys NV

Emittente

GLOBENEWSWIRE

1.00

29/05/2026

Results of the Ordinary Shareholders’ Meeting

Fonte

Biotalys NV

Emittente

GLOBENEWSWIRE

1.00

Seguaci

Compatibilità

Biotalys NV

Di cosa scriviamo

43 comunicati stampa

Recapiti

Social Media